|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/64 | |
| A61K 39/09 | |||
| A61K 39/095 | |||
| A61P 31/04 |
| (11) | Number of the document | 3421051 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18183661.0 |
| Date of filing the European patent application | 2013-08-12 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261684043 P | 2012-08-16 | US |
| (72) |
GU, Jianxin, US
KIM, Jin-hwan, US
PRASAD, Krishna A., US
YANG, Yu-ying, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | GLYCOCONJUGATION PROCESSES AND COMPOSITIONS |
| GLYCOCONJUGATION PROCESSES AND COMPOSITIONS |